Grail (GRAL) Current Assets (2023 - 2026)
Grail's (GRAL) quarterly Current Assets came in at $914.7 million in Q2 2026, up 40.33% on a YoY basis from $651.8 million in Q2 2025, and up 4.26% quarter-over-quarter from $877.3 million in Q1 2026.
Analysis
Grail (GRAL) Current Assets (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Current Assets for 4 consecutive years, with $914.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets rose 40.33% year-over-year to $914.7 million; the trailing twelve-month figure through Jun 2026 stood at $914.7 million (up 40.33% YoY), and the FY2025 full-year result was $953.8 million, up 16.34% from the prior year.
- Current Assets advanced to $914.7 million in Q2 2026 per GRAL's latest filing, from $877.3 million in the prior quarter.
- Across five years, Current Assets topped out at $1.0 billion in Q2 2024 and bottomed at $156.1 million in Q4 2023.
- Historically, Current Assets has averaged $761.9 million across 4 years, with a median of $848.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Assets soared 425.33% in 2024, then slumped 36.01% in 2025.
- Over 4 years, Current Assets stood at $156.1 million in 2023, then jumped by 425.33% to $819.9 million in 2024, then gained by 16.34% to $953.8 million in 2025, then declined by 4.1% to $914.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $914.7 million, $877.3 million, and $953.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 1.66 Bn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 2.84 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 3.81 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 1.36 Bn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 1.29 Bn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 1.06 Bn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 646.46 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 651.38 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 420.56 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 914.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 914.72 Mn |
| Mar 31, 2026 | 877.35 Mn |
| Dec 31, 2025 | 953.85 Mn |
| Sep 30, 2025 | 589.38 Mn |
| Jun 30, 2025 | 651.84 Mn |
| Mar 31, 2025 | 727.66 Mn |
| Dec 31, 2024 | 819.86 Mn |
| Sep 30, 2024 | 909.70 Mn |
| Jun 30, 2024 | 1.02 Bn |
| Dec 31, 2023 | 156.07 Mn |